Athyrium Capital Management Provides $102.3MM Term Loan to Calliditas
Swedish biopharmaceutical company Calliditas Therapeutics signed and fully drew on a term loan of €92 million ($102.3 million) with funds managed by Athyrium Capital Management.
December 28, 2023
Athyrium Capital Management | Calliditas Therapeutics | Kreos Capital | Laurent D. Hermouet | Renée Aguiar-Lucander
Ian Koplin